搜索优化
English
网页
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
3 小时
Pharma Stock Roundup: JNJ's Q4 Earnings, FDA Nod to AZN, Daiichi Drug
TikTok went dark on Sunday for US users as a new law banning the app took effect at midnight.
3 小时
J&J’s Q4 Earnings Beat but 2025 Outlook Dull
Failed to fetch dynamically imported module: https://sg.finance.yahoo.com/assets/_app/immutable/nodes/100.C0JpamNs.js ...
Boing Boing on MSN
4 小时
FDA approves J&J's patented psychedelic esketamine for depression without requiring you ...
On Tuesday, the US Food and Drug Administration (FDA) approved Johnson & Johnson's hallucinogenic drug esketamine (brand name ...
6 小时
Medical marijuana users can become addicted to pot, study says
People using weed for medical purposes are as likely -- or more -- to become addicted to cannabis as recreational tokers, a ...
Medscape
6 小时
FDA OKs Esketamine Nasal Spray Monotherapy for Resistant Depression
The expanded indication allows esketamine nasal spray to be used as a standalone treatment in adults with MDD who have not ...
TheHealthSite
7 小时
US FDA Approves First Of Its Kind Ketamine-Based Nasal Spray To Treat Depression: Know All ...
The US FDA has approved the first of its kind ketamine-based nasal spray which is supposed to act as a standalone therapy for ...
9 小时
Does Medicare cover ketamine infusions for mental health conditions?
Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...
TMCnet
12 小时
12 Press Releases You Need to See This Week
NEW YORK, Jan. 24, 2025 /PRNewswire/ -- With thousands of press releases published each week, it can be difficult to keep up ...
20 小时
on MSN
What happened in health news this week? | Health Smart
Here are the top health headlines for the week of Jan. 19, 2025. A nasal spray derived from ketamine gets federal clearance ...
ScienceAlert
22 小时
FDA-Approved Nasal Spray For Depression Is First Of Its Kind
A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression in the US.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈